"";"study";"in_MA_psyctr";"condition_arm1";"condition_arm2";"multi_arm1";"multi_arm2";"is.multiarm";"no.arms";"outcome_type";"sample";"instrument";"rating";"time";"time_weeks";"mean_arm1";"sd_arm1";"n_arm1";"mean_arm2";"sd_arm2";"n_arm2";"mean_change_arm1";"mean_change_arm2";"sd_change_arm1";"sd_change_arm2";"n_change_arm1";"n_change_arm2";"event_arm1";"event_arm2";"totaln_arm1";"totaln_arm2";"precalc_g";"precalc_g_se";"precalc_log_rr";"precalc_log_rr_se";"baseline_mean_arm1";"baseline_sd_arm1";"baseline_n_arm1";"baseline_mean_arm2";"baseline_sd_arm2";"baseline_n_arm2";"attr_arm1";"attr_arm2";"year";"comorbid_mental";"format";"n_sessions_arm1";"country";"age_group";"mean_age";"percent_women";"percent_adm_arm1";"percent_adm_arm2";"recruitment";"target_group";"domain 1";"domain 2";"domain 3";"domain 4";"domain 5";"ROB";"full_ref";".id";".g";".g_se";".log_rr";".log_rr_se";".event_arm1";".event_arm2";".totaln_arm1";".totaln_arm2"
"1";"Alcolado,2016";1;"ct";"wl";"NA";"NA";0;2;"other stat";"NR";"voci";"sr";"post";"3";NA;NA;12;NA;NA;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;-1,66;0,48;NA;NA;NA;NA;12;NA;NA;12;"NR";"NR";2016;"n";"ind";"2";"N America";"adul";33;"0.71";"NR";"NR";"com";"adul";"Some concerns";"Some concerns";"High risk";"Low risk";"Some concerns";"2";"Alcolado, G. M., & Radomsky, A. S. (2016). A novel cognitive intervention for compulsive checking: Targeting maladaptive beliefs about memory. Journal of Behavior Therapy and Experimental Psychiatry, 53, 75-83.";"Alcolado_2016_otherstat_voci_post_3_sr_ct_wl_NA_NA";1,66;0,48;NA;NA;NA;NA;NA;NA
"2";"Anderson,2007";1;"cbt";"wl";"cbt(grp)";"wl";1;3;"msd";"co";"ybocs";"cr";"post";"10";18,1;7,7;20;23,5;6,4;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.4";"7.3";25;"24.1";"5.0999999999999996";17;"5";"3";2007;"n";"grp";"9";"au";"adul";35;"0.74";"0.65";"0.56999999999999995";"clin";"adul";"Some concerns";"Low risk";"Some concerns";"High risk";"Some concerns";"2";"Anderson, R. A., & Rees, C. S. (2007). Group versus individual cognitive-behavioural treatment for obsessive-compulsive disorder: a controlled trial. Behav Res Ther, 45(1), 123-137.";"Anderson_2007_msd_ybocs_post_10_cr_cbt_wl_cbt(grp)_wl";0,73225918698949;0,360138975632893;NA;NA;NA;NA;NA;NA
"3";"Anderson,2007";1;"cbt";"wl";"cbt(ind)";"wl";1;3;"msd";"co";"ybocs";"cr";"post";"10";16,7;6,8;17;23,5;6,4;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24";"6.2";21;"24.1";"5.0999999999999996";17;"4";"3";2007;"n";"ind";"10";"au";"adul";33;"0.66";"0.65";"0.56999999999999995";"clin";"adul";"Some concerns";"Low risk";"Some concerns";"High risk";"Some concerns";"2";"Anderson, R. A., & Rees, C. S. (2007). Group versus individual cognitive-behavioural treatment for obsessive-compulsive disorder: a controlled trial. Behav Res Ther, 45(1), 123-137.";"Anderson_2007_msd_ybocs_post_10_cr_cbt_wl_cbt(ind)_wl";0,999838640832884;0,383733336178153;NA;NA;NA;NA;NA;NA
"4";"Andersson,2012";1;"cbt";"psychological placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"10";12,94;6,26;49;18,88;4,18;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"21.42";"4.59";50;"20.8";"4.04";51;"2";"0";2012;"n";"gsh";"7";"eu";"adul";34;"0.66";"0.2";"0.25";"com";"adul";"Low risk";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"Andersson, E., Enander, J., Andrén, P., Hedman, E., Ljótsson, B., Hursti, T., . . . Rück, C. (2012). Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med, 42(10), 2193-2203.";"Andersson_2012_msd_ybocs_post_10_cr_cbt_psychologicalplacebo_NA_NA";1,11179118015687;0,215156564378041;NA;NA;NA;NA;NA;NA
"5";"Andersson,2012";1;"cbt";"psychological placebo";"NA";"NA";0;2;"msd";"co";"oci-r";"cr";"post";"10";12,5;10,15;48;19,22;11,52;51;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.36";"13.25";50;"19.86";"9.48";51;"2";"0";2012;"n";"gsh";"7";"eu";"adul";34;"0.66";"0.2";"0.25";"com";"adul";"Low risk";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"Andersson, E., Enander, J., Andrén, P., Hedman, E., Ljótsson, B., Hursti, T., . . . Rück, C. (2012). Internet-based cognitive behaviour therapy for obsessive-compulsive disorder: a randomized controlled trial. Psychol Med, 42(10), 2193-2203.";"Andersson_2012_msd_oci-r_post_10_cr_cbt_psychologicalplacebo_NA_NA";0,612985614388741;0,205836533574939;NA;NA;NA;NA;NA;NA
"6";"Barrett,2003";1;"cbt";"wl";"NA";"NA";1;2;"other stat";"NR";"nimh-gocs";"cr";"post";"14";NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;-3,59;0,67;NA;NA;NA;NA;12;NA;NA;12;"NR";"NR";2003;"n";"FB";"14";"au";"child";11;"0.42";"NR";"NR";"com";"child and adol";"Some concerns";"High risk";"High risk";"High risk";"Some concerns";"2";"Barrett, P., Healy, L., & March, J. S. (2003). Behavioral avoidance test for childhood obsessive-compulsive disorder: A home-based observation. American Journal of Psychotherapy, 57(1), 80-100.";"Barrett_2003_otherstat_nimh-gocs_post_14_cr_cbt_wl_NA_NA";3,59;0,67;NA;NA;NA;NA;NA;NA
"7";"Barrett,2003";1;"cbt";"wl";"NA";"NA";1;2;"other stat";"NR";"cy-bocs";"cr";"post";"14";NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;-2,58;0,56;NA;NA;NA;NA;12;NA;NA;12;"NR";"NR";2003;"n";"FB";"14";"au";"child";11;"0.42";"NR";"NR";"com";"child and adol";"Some concerns";"High risk";"High risk";"High risk";"Some concerns";"2";"Barrett, P., Healy, L., & March, J. S. (2003). Behavioral avoidance test for childhood obsessive-compulsive disorder: A home-based observation. American Journal of Psychotherapy, 57(1), 80-100.";"Barrett_2003_otherstat_cy-bocs_post_14_cr_cbt_wl_NA_NA";2,58;0,56;NA;NA;NA;NA;NA;NA
"8";"Barrett,2004";1;"cbt";"wl";"cbft(ind)";"wl";1;3;"msd";"co";"nimh-gocs";"cr";"post";"14";3,5;2,3;24;9;2;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"8.7899999999999991";"1.62";24;"8.67";"1.81";24;"NR";"NR";2004;"n";"FB";"14";"au";"child";11;"0.48";"0.13";"0.21";"com";"child and adol";"Some concerns";"High risk";"Low risk";"Low risk";"Some concerns";"2";"Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62.";"Barrett_2004_msd_nimh-gocs_post_14_cr_cbt_wl_cbft(ind)_wl";2,51010128308008;0,388806653187636;NA;NA;NA;NA;NA;NA
"9";"Barrett,2004";1;"cbt";"wl";"cbft(grp)";"wl";1;3;"msd";"co";"nimh-gocs";"cr";"post";"14";3,31;2,16;29;9;2;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"8.83";"1.37";29;"8.67";"1.81";24;"NR";"NR";2004;"n";"FB";"14";"au";"child";12;"0.51";"0.31";"0.21";"com";"child and adol";"Some concerns";"High risk";"Low risk";"Low risk";"Some concerns";"2";"Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62.";"Barrett_2004_msd_nimh-gocs_post_14_cr_cbt_wl_cbft(grp)_wl";2,68307514784552;0,382251495889957;NA;NA;NA;NA;NA;NA
"10";"Barrett,2004";1;"cbt";"wl";"cbft(ind)";"wl";1;3;"msd";"co";"cy-bocs";"cr";"post";"14";8,36;6,93;22;24,04;4,14;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"23.64";"4.3";24;"22.95";"5.49";24;"NR";"NR";2004;"n";"FB";"14";"au";"child";11,25;"0.48";"0.13";"0.21";"com";"child and adol";"Some concerns";"High risk";"Low risk";"Low risk";"Some concerns";"2";"Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62.";"Barrett_2004_msd_cy-bocs_post_14_cr_cbt_wl_cbft(ind)_wl";2,72945022874709;0,413458328762379;NA;NA;NA;NA;NA;NA
"11";"Barrett,2004";1;"cbt";"wl";"cbft(grp)";"wl";1;3;"msd";"co";"cy-bocs";"cr";"post";"14";8,28;7,33;29;24,04;4,14;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"21.38";"5.62";29;"22.95";"5.49";24;"NR";"NR";2004;"n";"FB";"14";"au";"child";12,4;"0.51";"0.31";"0.21";"com";"child and adol";"Some concerns";"High risk";"Low risk";"Low risk";"Some concerns";"2";"Barrett, P., Healy-Farrell, L., & March, J. S. (2004). Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial. J Am Acad Child Adolesc Psychiatry, 43(1), 46-62.";"Barrett_2004_msd_cy-bocs_post_14_cr_cbt_wl_cbft(grp)_wl";2,54481510116887;0,372949268332186;NA;NA;NA;NA;NA;NA
"12";"Bolton-Perrin,2008";1;"erp";"wl";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"7";13,39;8,22;10;21,61;8,22;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24";"4.78";10;"22";"8.25";10;"2";"0";2008;"n";"ind";"9";"uk";"adol";13;"0.3";"0";"0";"clin";"adol";"Low risk";"Low risk";"High risk";"High risk";"Some concerns";"2";"Bolton, D., & Perrin, S. (2008). Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. J Behav Ther Exp Psychiatry, 39(1), 11-22.";"Bolton-Perrin_2008_msd_cy-bocs_post_7_cr_erp_wl_NA_NA";0,957746478873239;0,474341649025257;NA;NA;NA;NA;NA;NA
"13";"Bolton,2011";1;"cbt";"wl";"cbt(full)";"wl";1;3;"msd";"itt";"cy-bocs";"cr";"post";"12";9,5;8;36;23,3;8,3;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22.3";"5";36;"24.2";"5";24;"2";"3";2011;"n";"ind";"12";"uk";"adol";15;"0.56000000000000005";"0.11";"0.21";"clin";"adol";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278.";"Bolton_2011_msd_cy-bocs_post_12_cr_cbt_wl_cbt(full)_wl";1,6773755990675;0,305797470613576;NA;NA;NA;NA;NA;NA
"14";"Bolton,2011";1;"cbt";"wl";"cbt(full)";"wl";1;3;"msd";"itt";"oci";"sr";"post";"12";21,6;22,8;36;67,8;31,3;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"67.900000000000006";"31.3";36;"68.400000000000006";"32.9";24;"2";"3";2011;"n";"ind";"12";"uk";"adol";15;"0.56000000000000005";"0.11";"0.21";"clin";"adol";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278.";"Bolton_2011_msd_oci_post_12_sr_cbt_wl_cbt(full)_wl";1,72082295047114;0,307855550365248;NA;NA;NA;NA;NA;NA
"15";"Bolton,2011";1;"cbt";"wl";"cbt(brief)";"wl";1;3;"msd";"itt";"cy-bocs";"cr";"post";"12";13;9,6;36;23,3;8,3;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22";"6.9";36;"24.2";"5";24;"2";"3";2011;"n";"ind";"5";"uk";"adol";14;"0.6";"0.06";"0.21";"clin";"adol";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278.";"Bolton_2011_msd_cy-bocs_post_12_cr_cbt_wl_cbt(brief)_wl";1,1163448939104;0,283027831873959;NA;NA;NA;NA;NA;NA
"16";"Bolton,2011";1;"cbt";"wl";"cbt(brief)";"wl";1;3;"msd";"itt";"oci";"sr";"post";"12";36,9;38,4;36;67,8;31,3;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"68.099999999999994";"36.200000000000003";36;"68.400000000000006";"32.9";24;"2";"3";2011;"n";"ind";"5";"uk";"adol";14;"0.6";"0.06";"0.21";"clin";"adol";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Bolton, D., Williams, T., Perrin, S., Atkinson, L., Gallop, C., Waite, P., & Salkovskis, P. (2011). Randomized controlled trial of full and brief cognitive-behaviour therapy and wait-list for paediatric obsessive-compulsive disorder. J Child Psychol Psychiatry, 52(12), 1269-1278.";"Bolton_2011_msd_oci_post_12_sr_cbt_wl_cbt(brief)_wl";0,85302511554768;0,275079683795284;NA;NA;NA;NA;NA;NA
"17";"Braga,2016";1;"cbt";"wl";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"12";14,1;8,4;61;23,5;6,4;42;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"27.4";"5.8";61;"26.2";"5";42;"14";"33";2016;"n";"grp";"12";"eu";"adul";43;"0.67";"0.53";"0.41";"com";"adul";"Some concerns";"High risk";"High risk";"High risk";"Some concerns";"2";"Braga, D. T., Abramovitch, A., Fontenelle, L. F., Ferrão, Y. A., Gomes, J. B., Vivan, A. S., . . . Cordioli, A. V. (2016). Neuropsychological predictors of treatment response to cognitive behavioral group therapy in obsessive-compulsive disorder. Depress Anxiety, 33(9), 848-861.";"Braga_2016_msd_ybocs_post_12_cr_cbt_wl_NA_NA";1,21938546830796;0,218012860997133;NA;NA;NA;NA;NA;NA
"18";"Challacombe,2017";1;"cbt";"cau";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"26";13,71;8,95;17;20,88;6,34;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.82";"5.19";17;"24.47";"5.81";17;"0";"1";2017;"n";"TI";"4";"uk";"adul";33;"1";"0.41";"0.64";"com";"ppd";"Some concerns";"Low risk";"Low risk";"Low risk";"Some concerns";"2";"Challacombe, F. L., Salkovskis, P. M., Woolgar, M., Wilkinson, E. L., Read, J., & Acheson, R. (2017). A pilot randomized controlled trial of time-intensive cognitive–behaviour therapy for postpartum obsessive–compulsive disorder: Effects on maternal symptoms, mother–infant interactions and attachment. Psychological Medicine, 47(8), 1478-1488.";"Challacombe_2017_msd_ybocs_post_26_cr_cbt_cau_NA_NA";0,897159250798138;0,366246221569807;NA;NA;NA;NA;NA;NA
"19";"Challacombe,2017";1;"cbt";"cau";"NA";"NA";0;2;"msd";"co";"oci-r";"sr";"post";"26";26,18;23,8;17;52,23;30,96;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"53.88";"23.11";17;"61.82";"27.95";17;"0";"1";2017;"n";"TI";"4";"uk";"adul";33;"1";"0.41";"0.64";"com";"ppd";"Some concerns";"Low risk";"Low risk";"Low risk";"Some concerns";"2";"Challacombe, F. L., Salkovskis, P. M., Woolgar, M., Wilkinson, E. L., Read, J., & Acheson, R. (2017). A pilot randomized controlled trial of time-intensive cognitive–behaviour therapy for postpartum obsessive–compulsive disorder: Effects on maternal symptoms, mother–infant interactions and attachment. Psychological Medicine, 47(8), 1478-1488.";"Challacombe_2017_msd_oci-r_post_26_sr_cbt_cau_NA_NA";0,924225403702928;0,367316002964705;NA;NA;NA;NA;NA;NA
"20";"Cordioli,2003";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"ybocs";"cr";"post";"12";15,1;7,8;23;23,2;5,5;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26.7";"4.9000000000000004";23;"24.7";"5.2";24;"1";"1";2003;"n";"grp";"12";"oth";"adul";37;"0.51";"0.43";"0.46";"com";"adul";"Low risk";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"Cordioli, A. V., Heldt, E., Bochi, D. B., Margis, R., De Sousa, M. B., Tonello, J. F., . . . Kapczinski, F. (2003). Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial. Psychotherapy and Psychosomatics, 72(4), 211-216.";"Cordioli_2003_msd_ybocs_post_12_cr_cbt_wl_NA_NA";1,18454314880034;0,317151680970298;NA;NA;NA;NA;NA;NA
"21";"Cordioli,2003";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"nimh-oc";"cr";"post";"12";5,2;2,6;23;8;1,8;24;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"8.6";"1.3";23;"8";"1.5";24;"1";"1";2003;"n";"grp";"12";"oth";"adul";37;"0.51";"0.43";"0.46";"com";"adul";"Low risk";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"Cordioli, A. V., Heldt, E., Bochi, D. B., Margis, R., De Sousa, M. B., Tonello, J. F., . . . Kapczinski, F. (2003). Cognitive-behavioral group therapy in obsessive-compulsive disorder: A randomized clinical trial. Psychotherapy and Psychosomatics, 72(4), 211-216.";"Cordioli_2003_msd_nimh-oc_post_12_cr_cbt_wl_NA_NA";1,23605534841459;0,319307514199987;NA;NA;NA;NA;NA;NA
"22";"Fals-Stewart-Schafer,1992";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"co";"nimh-oc";"cr";"post";"6";8,1;3,1;19;13;3,6;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"14.2";"3.6";20;"13.8";"3.5";20;"1";"2";1992;"y";"ind";"18";"N America";"adul";33;"0.26";"NR";"NR";"oth";"oth";"Some concerns";"High risk";"Some concerns";"High risk";"Some concerns";"2";"Fals-Stewart, W., & Schafer, J. (1992). The treatment of substance abusers diagnosed with obsessive-compulsive disorder: an outcome study. J Subst Abuse Treat, 9(4), 365-370.";"Fals-Stewart-Schafer_1992_msd_nimh-oc_post_6_cr_erp_psychologicalplacebo_NA_NA";1,43018506037417;0,370217468547198;NA;NA;NA;NA;NA;NA
"23";"Foa,2005";1;"erp";"pill placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"12";11;7,9;21;22,2;6,4;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.6";"4.8";29;"25";"4";26;"16";"12";2005;"n";"ind";"15";"N America";"adul";34;"0.51";"NR";"NR";"com";"adul";"Some concerns";"Low risk";"High risk";"Low risk";"Some concerns";"2";"Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., . . . Tu, X. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 162(1), 151-161.";"Foa_2005_msd_ybocs_post_12_cr_erp_pillplacebo_NA_NA";1,52368552314169;0,356454879415902;NA;NA;NA;NA;NA;NA
"24";"Foa,2005";1;"erp";"pill placebo";"NA";"NA";0;2;"msd";"co";"nimh-oc";"cr";"post";"12";4,3;3;21;8,8;1,8;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"9,1";"1,6";29;"8,9";"1,8";26;"16";"12";2005;"n";"ind";"15";"N America";"adul";34;"0.51";"NR";"NR";"com";"adul";"Some concerns";"Low risk";"High risk";"Low risk";"Some concerns";"2";"Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., . . . Tu, X. (2005). Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry, 162(1), 151-161.";"Foa_2005_msd_nimh-oc_post_12_cr_erp_pillplacebo_NA_NA";1,77314477482885;0,370795716114983;NA;NA;NA;NA;NA;NA
"25";"Freeman,2008";1;"cbt";"psychological placebo";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"14";14,45;8,16;22;17,1;7,57;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22.95";"3.84";22;"22";"4.5199999999999996";20;"1";"1";2008;"n";"FB";"12";"N America";"child";7;"0.56999999999999995";"NR";"NR";"com";"child";"Some concerns";"Low risk";"Low risk";"Low risk";"Some concerns";"2";"Freeman, J. B., Garcia, A. M., Coyne, L., Ale, C., Przeworski, A., Himle, M., . . . Leonard, H. L. (2008). Early childhood OCD: Preliminary findings from a family-based cognitive-behavioral approach. Journal of the American Academy of Child & Adolescent Psychiatry, 47(5), 593-602.";"Freeman_2008_msd_cy-bocs_post_14_cr_cbt_psychologicalplacebo_NA_NA";0,329729293365413;0,311125549326634;NA;NA;NA;NA;NA;NA
"26";"Freeman,2014";1;"cbt";"psychological placebo";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"14";12,3;5,5;63;19,67;5,6;64;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.13";"4.46";63;"25.97";"3.98";64;"2";"6";2014;"n";"FB";"12";"N America";"child";7;"0.53";"0.95";"0.06";"com";"child";"Some concerns";"Low risk";"Some concerns";"Low risk";"Low risk";"2";"Freeman, J., Sapyta, J., Garcia, A., Compton, S., Khanna, M., Flessner, C., . . . Benito, K. (2014). Family-based treatment of early childhood obsessive-compulsive disorder: The Pediatric Obsessive-Compulsive Disorder Treatment Study for Young Children (POTS Jr)—A randomized clinical trial. JAMA psychiatry, 71(6), 689-698.";"Freeman_2014_msd_cy-bocs_post_14_cr_cbt_psychologicalplacebo_NA_NA";1,31979572246153;0,19605851809427;NA;NA;NA;NA;NA;NA
"27";"Freeston,1997";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"ybocs";"cr";"post";"16";12,2;9,6;15;22;6;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.1";"5";15;"21.2";"6";14;"NR";"NR";1997;"n";"ind";"26";"N America";"adul";36;"0.45";"0.33";"0.36";"oth";"adul";"Some concerns";"Low risk";"High risk";"High risk";"Some concerns";"2";"Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rhéaume, J., Letarte, H., & Bujold, A. (1997). Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol, 65(3), 405-413.";"Freeston_1997_msd_ybocs_post_16_cr_cbt_wl_NA_NA";1,18037075645062;0,404379889979271;NA;NA;NA;NA;NA;NA
"28";"Freeston,1997";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"padua";"sr";"post";"16";54,7;32,9;15;83,9;35,6;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"71.5";"31.4";15;"87.1";"43.4";14;"NR";"NR";1997;"n";"ind";"26";"N America";"adul";36;"0.45";"0.33";"0.36";"oth";"adul";"Some concerns";"Low risk";"High risk";"High risk";"Some concerns";"2";"Freeston, M. H., Ladouceur, R., Gagnon, F., Thibodeau, N., Rhéaume, J., Letarte, H., & Bujold, A. (1997). Cognitive-behavioral treatment of obsessive thoughts: a controlled study. J Consult Clin Psychol, 65(3), 405-413.";"Freeston_1997_msd_padua_post_16_sr_cbt_wl_NA_NA";0,82921792403291;0,388129193222705;NA;NA;NA;NA;NA;NA
"29";"Gomes,2016";1;"cbt";"wl";"NA";"NA";0;2;"msd";"NR";"ybocs";"cr";"post";"13";13,8;8,54;46;24,7;5,37;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"27.3";"5.7";52;"26.4";"5.43";46;"6";"7";2016;"n";"FB";"12";"oth";"adul";41;"0.62";"0.5";"0.59";"com";"adul";"Low risk";"Some concerns";"Some concerns";"High risk";"Some concerns";"2";"Gomes, J. B., Cordioli, A. V., Bortoncello, C. F., Braga, D. T., Gonçalves, F., & Heldt, E. (2016). Impact of cognitive-behavioral group therapy for obsessive-compulsive disorder on family accommodation: A randomized clinical trial. Psychiatry Res, 246, 70-76.";"Gomes_2016_msd_ybocs_post_13_cr_cbt_wl_NA_NA";1,48726101968062;0,246233023659058;NA;NA;NA;NA;NA;NA
"30";"Gomes,2016";1;"cbt";"wl";"NA";"NA";0;2;"msd";"NR";"oci-r";"sr";"post";"13";15,8;14,04;46;34,5;15,05;39;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"34.5";"16";52;"33.9";"13.6";46;"6";"7";2016;"n";"FB";"12";"oth";"adul";41;"0.62";"0.5";"0.59";"com";"adul";"Low risk";"Some concerns";"Some concerns";"High risk";"Some concerns";"2";"Gomes, J. B., Cordioli, A. V., Bortoncello, C. F., Braga, D. T., Gonçalves, F., & Heldt, E. (2016). Impact of cognitive-behavioral group therapy for obsessive-compulsive disorder on family accommodation: A randomized clinical trial. Psychiatry Res, 246, 70-76.";"Gomes_2016_msd_oci-r_post_13_sr_cbt_wl_NA_NA";1,27698564376067;0,23905801685151;NA;NA;NA;NA;NA;NA
"31";"Greist,2002";1;"erp";"psychological placebo";"erp(ind)";"psychological placebo";1;3;"msd";"NR";"ybocs";"sr";"post";"10";17,6;6,2;55;24,1;6,7;66;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.2";"4.5999999999999996";55;"25.8";"5.0999999999999996";66;"14";"9";2002;"n";"ind";"11";"N America";"adul";39;"0.42";"NR";"NR";"com";"adul";"Some concerns";"Low risk";"High risk";"Low risk";"Some concerns";"2";"Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., . . . Clary, C. M. (2002). Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry, 63(2), 138-145.";"Greist_2002_msd_ybocs_post_10_sr_erp_psychologicalplacebo_erp(ind)_psychologicalplacebo";0,997075203544857;0,193633198907312;NA;NA;NA;NA;NA;NA
"32";"Greist,2002";1;"erp";"psychological placebo";"erp(ush)";"psychological placebo";1;3;"msd";"co";"ybocs";"sr";"post";"10";19;7,2;55;24,1;6,7;66;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.6";"4.3";55;"25.8";"5.0999999999999996";66;"19";"9";2002;"n";"ush";"9";"oth";"adul";39;"0.42";"NR";"NR";"com";"adul";"Some concerns";"Low risk";"High risk";"Low risk";"Some concerns";"2";"Greist, J. H., Marks, I. M., Baer, L., Kobak, K. A., Wenzel, K. W., Hirsch, M. J., . . . Clary, C. M. (2002). Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry, 63(2), 138-145.";"Greist_2002_msd_ybocs_post_10_sr_erp_psychologicalplacebo_erp(ush)_psychologicalplacebo";0,731139038820659;0,188601287700994;NA;NA;NA;NA;NA;NA
"33";"Herbst,2014";1;"erp";"wl";"NA";"NA";0;2;"msd";"itt";"ybocs";"sr";"post";"8";14,44;5,9;16;19,33;6,46;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"20.25";"6.71";16;"20";"5.4";18;"0";"3";2014;"n";"gsh";"14";"eu";"adul";36;"0.65";"0.26";"0.26";"com";"adul";"Some concerns";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Herbst, N., Voderholzer, U., Thiel, N., Schaub, R., Knaevelsrud, C., Stracke, S., . . . Külz, A. K. (2014). No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder. Psychother Psychosom, 83(3), 165-175.";"Herbst_2014_msd_ybocs_post_8_sr_erp_wl_NA_NA";0,769607389856221;0,35664035807798;NA;NA;NA;NA;NA;NA
"34";"Herbst,2014";1;"erp";"wl";"NA";"NA";0;2;"msd";"itt";"oci-r";"sr";"post";"8";15,56;8,93;16;24,11;10,84;18;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26";"10.3";16;"25.89";"9.99";18;"0";"3";2014;"n";"gsh";"14";"eu";"adul";36;"0.65";"0.26";"0.26";"com";"adul";"Some concerns";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Herbst, N., Voderholzer, U., Thiel, N., Schaub, R., Knaevelsrud, C., Stracke, S., . . . Külz, A. K. (2014). No talking, just writing! Efficacy of an Internet-based cognitive behavioral therapy with exposure and response prevention in obsessive compulsive disorder. Psychother Psychosom, 83(3), 165-175.";"Herbst_2014_msd_oci-r_post_8_sr_erp_wl_NA_NA";0,835617136856314;0,358924641165612;NA;NA;NA;NA;NA;NA
"35";"Khodarahimi,2009";1;"erp";"wl";"erp";"wl";1;3;"msd";"co";"ybocs";"sr";"post";"6";5,58;10,69;20;36,45;10,02;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"37.200000000000003";"8.5399999999999991";20;"36.4";"10.11";20;"NR";"NR";2009;"n";"ind";"12";"oth";"adul";25;"0";"0";"0";"com";"adul";"Some concerns";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207.";"Khodarahimi_2009_msd_ybocs_post_6_sr_erp_wl_erp_wl";2,92041212150507;0,459321153345249;NA;NA;NA;NA;NA;NA
"36";"Khodarahimi,2009";1;"other psy";"wl";"other psy";"wl";1;3;"msd";"co";"ybocs";"sr";"post";"6";6,4;9,43;20;36,45;10,02;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"37.1";"8.81";20;"36.4";"10.11";20;"NR";"NR";2009;"n";"ind";"12";"oth";"adul";25;"0";"0";"0";"com";"adul";"Some concerns";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"Khodarahimi, S. (2009). Satiation therapy and exposure response prevention in the treatment of obsessive compulsive disorder. Journal of Contemporary Psychotherapy, 39(3), 203-207.";"Khodarahimi_2009_msd_ybocs_post_6_sr_otherpsy_wl_otherpsy_wl";3,02719164054178;0,468230225763666;NA;NA;NA;NA;NA;NA
"37";"Kobayashi,2020";1;"erp";"cau";"NA";"NA";0;2;"msd";"itt";"ybocs";"cr";"post";"16";16,62;6,19;9;26,38;4,72;8;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26.67";"5.5";9;"27.75";"3.24";8;"1";"1";2020;"n";"FB";"24";"oth";"adul";30;"0.47";"0.89";"0.88";"clin";"adul";"Low risk";"Low risk";"Some concerns";"Low risk";"Low risk";"1";"Kobayashi, Y., Kanie, A., Nakagawa, A., Takebayashi, Y., Shinmei, I., Nakayama, N., . . . Mimura, M. (2020). An evaluation of family-based treatment for OCD in Japan: a pilot randomized controlled trial. Frontiers in Psychiatry, 10, 932.";"Kobayashi_2020_msd_ybocs_post_16_cr_erp_cau_NA_NA";1,66834594937256;0,571822758676799;NA;NA;NA;NA;NA;NA
"38";"Kyrios,2018";1;"cbt";"psychological placebo";"NA";"NA";0;2;"msd";"itt";"ybocs";"cr";"post";"12";15,86;5,65;89;19,15;6,45;90;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22.44";"5.36";89;"22.13";"5.73";90;"37";"27";2018;"n";"gsh";"12";"au";"adul";33;"0.66";"0.71";"0.75";"com";"adul";"Low risk";"Low risk";"High risk";"Low risk";"High risk";"2";"Kyrios, M., Ahern, C., Fassnacht, D. B., Nedeljkovic, M., Moulding, R., & Meyer, D. (2018). Therapist-Assisted Internet-Based Cognitive Behavioral Therapy Versus Progressive Relaxation in Obsessive-Compulsive Disorder: Randomized Controlled Trial. J Med Internet Res, 20(8), e242.";"Kyrios_2018_msd_ybocs_post_12_cr_cbt_psychologicalplacebo_NA_NA";0,54011366654452;0,152213317234354;NA;NA;NA;NA;NA;NA
"39";"Launes,2019";1;"erp";"wl";"erp(intensive)";"wl";1;3;"msd";"co";"ybocs";"cr";"post";"12";10,9;4,35;16;27,32;4,14;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26.75";"4.2300000000000004";16;"26.88";"3.93";15;"0";"1";2019;"n";"oth";"NR";"eu";"adul";32;"0.78";"0.25";"0.25";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500.";"Launes_2019_msd_ybocs_post_12_cr_erp_wl_erp(intensive)_wl";3,76281567892582;0,608220300460644;NA;NA;NA;NA;NA;NA
"40";"Launes,2019";1;"erp";"wl";"erp(intensive)";"wl";1;3;"msd";"co";"docs-sf";"sr";"post";"12";13,44;7,08;16;25,24;5,43;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26.56";"3.81";16;"28.56";"6.29";15;"0";"1";2019;"n";"oth";"NR";"eu";"adul";32;"0.78";"0.25";"0.25";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500.";"Launes_2019_msd_docs-sf_post_12_sr_erp_wl_erp(intensive)_wl";1,81341424123157;0,43021622542531;NA;NA;NA;NA;NA;NA
"41";"Launes,2019";1;"erp";"wl";"erp(intensive)";"wl";1;3;"msd";"co";"oci-r";"sr";"post";"12";7,94;5,94;16;25,19;13,38;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22.69";"12.42";16;"27.69";"14.42";15;"0";"1";2019;"n";"oth";"NR";"eu";"adul";32;"0.78";"0.25";"0.25";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500.";"Launes_2019_msd_oci-r_post_12_sr_erp_wl_erp(intensive)_wl";1,64204979660704;0,418350091315225;NA;NA;NA;NA;NA;NA
"42";"Launes,2019";1;"erp";"wl";"erp(ush)";"wl";1;3;"msd";"co";"ybocs";"cr";"post";"12";24,63;6,18;16;27,32;4,14;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"27.88";"4.22";16;"26.88";"3.93";15;"0";"1";2019;"n";"ush";"NR";"eu";"adul";29;"0.75";"0.25";"0.25";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500.";"Launes_2019_msd_ybocs_post_12_cr_erp_wl_erp(ush)_wl";0,49484458341222;0,365144652773159;NA;NA;NA;NA;NA;NA
"43";"Launes,2019";1;"erp";"wl";"erp(ush)";"wl";1;3;"msd";"co";"docs-sf";"sr";"post";"12";24,63;6,47;16;25,24;5,43;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"28.69";"3.61";16;"28.56";"6.29";15;"0";"1";2019;"n";"ush";"NR";"eu";"adul";29;"0.75";"0.25";"0.25";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500.";"Launes_2019_msd_docs-sf_post_12_sr_erp_wl_erp(ush)_wl";0,0991712530840601;0,359630235702226;NA;NA;NA;NA;NA;NA
"44";"Launes,2019";1;"erp";"wl";"erp(ush)";"wl";1;3;"msd";"co";"oci-r";"sr";"post";"12";22;13,14;16;25,19;13,38;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"29.25";"15.29";16;"27.69";"14.42";15;"0";"1";2019;"n";"ush";"NR";"eu";"adul";29;"0.75";"0.25";"0.25";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Launes, G., Hagen, K., Sunde, T., Öst, L.-G., Klovning, I., Laukvik, I.-L., . . . Hansen, B. (2019). A randomized controlled trial of concentrated ERP, self-help and waiting list for obsessive-compulsive disorder: the Bergen 4-day treatment. Frontiers in Psychology, 10, 2500.";"Launes_2019_msd_oci-r_post_12_sr_erp_wl_erp(ush)_wl";0,234360877625045;0,360694674147815;NA;NA;NA;NA;NA;NA
"45";"Lenhard,2017";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"12";16,97;6,29;33;20,64;4,11;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"23";"4.3099999999999996";33;"22.12";"3.91";34;"0";"1";2017;"n";"FB";"12";"eu";"adol";15;"0.46";"0.28000000000000003";"0.18";"com";"adol";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Lenhard, F., Andersson, E., Mataix-Cols, D., Rück, C., Vigerland, S., Högström, J., . . . Serlachius, E. (2017). Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry, 56(1), 10-19.e12.";"Lenhard_2017_msd_cy-bocs_post_12_cr_cbt_wl_NA_NA";0,684874807331692;0,25159037260984;NA;NA;NA;NA;NA;NA
"46";"Lenhard,2017";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"choci-r-c";"sr";"post";"12";19,96;7,83;33;24,68;6,93;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.48";"6.72";33;"25.38";"7.71";34;"0";"1";2017;"n";"FB";"12";"eu";"adol";15;"0.46";"0.28000000000000003";"0.18";"com";"adol";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Lenhard, F., Andersson, E., Mataix-Cols, D., Rück, C., Vigerland, S., Högström, J., . . . Serlachius, E. (2017). Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry, 56(1), 10-19.e12.";"Lenhard_2017_msd_choci-r-c_post_12_sr_cbt_wl_NA_NA";0,631576922542203;0,250522970763338;NA;NA;NA;NA;NA;NA
"47";"Lenhard,2017";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"choci-r-p";"sr";"post";"12";19,32;9,88;33;25,25;10,04;34;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.42";"7.56";33;"25.56";"8.36";34;"0";"1";2017;"n";"FB";"12";"eu";"adol";15;"0.46";"0.28000000000000003";"0.18";"com";"adol";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Lenhard, F., Andersson, E., Mataix-Cols, D., Rück, C., Vigerland, S., Högström, J., . . . Serlachius, E. (2017). Therapist-Guided, Internet-Delivered Cognitive-Behavioral Therapy for Adolescents With Obsessive-Compulsive Disorder: A Randomized Controlled Trial. J Am Acad Child Adolesc Psychiatry, 56(1), 10-19.e12.";"Lenhard_2017_msd_choci-r-p_post_12_sr_cbt_wl_NA_NA";0,588393533503894;0,249718516924853;NA;NA;NA;NA;NA;NA
"48";"Lewin,2014";1;"erp";"cau";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"7";12,29;8,61;17;24;4,35;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.47";"5.8";17;"24.5";"5.68";14;"0";"0";2014;"n";"FB";"12";"N America";"child";6;"0.28999999999999998";"0.06";"0.43";"clin";"child";"Some concerns";"Low risk";"Low risk";"Low risk";"Some concerns";"2";"Lewin, A. B., Park, J. M., Jones, A. M., Crawford, E. A., De Nadai, A. S., Menzel, J., . . . Storch, E. A. (2014). Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial. Behav Res Ther, 56, 30-38.";"Lewin_2014_msd_cy-bocs_post_7_cr_erp_cau_NA_NA";1,62288773857863;0,41837587390809;NA;NA;NA;NA;NA;NA
"49";"Lindsay,1997";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"NR";"ybocs";"cr";"post";"3";11;3,81;9;25,89;5,8;9;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"28.7";"4.5599999999999996";9;"24.44";"6.98";9;"0";"0";1997;"n";"ind";"15";"au";"adul";33;"0.67";"0.28000000000000003";"0.28000000000000003";"clin";"adul";"Some concerns";"Some concerns";"Low risk";"High risk";"Some concerns";"2";"Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry, 171, 135-139.";"Lindsay_1997_msd_ybocs_post_3_cr_erp_psychologicalplacebo_NA_NA";2,88997937083339;0,691376621759009;NA;NA;NA;NA;NA;NA
"50";"Lindsay,1997";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"NR";"moci";"sr";"post";"3";9,56;4,59;9;17,89;4,23;9;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"17";"4.0599999999999996";9;"20.329999999999998";"4.0599999999999996";9;"0";"0";1997;"n";"ind";"15";"au";"adul";33;"0.67";"0.28000000000000003";"0.28000000000000003";"clin";"adul";"Some concerns";"Some concerns";"Low risk";"High risk";"Some concerns";"2";"Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry, 171, 135-139.";"Lindsay_1997_msd_moci_post_3_sr_erp_psychologicalplacebo_NA_NA";1,79744517488993;0,566714877735916;NA;NA;NA;NA;NA;NA
"51";"Lindsay,1997";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"NR";"padua";"sr";"post";"3";41,44;22,54;9;81,22;35,15;9;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"84.56";"28.36";9;"95.78";"39.44";9;"0";"0";1997;"n";"ind";"15";"au";"adul";33;"0.67";"0.28000000000000003";"0.28000000000000003";"clin";"adul";"Some concerns";"Some concerns";"Low risk";"High risk";"Some concerns";"2";"Lindsay, M., Crino, R., & Andrews, G. (1997). Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry, 171, 135-139.";"Lindsay_1997_msd_padua_post_3_sr_erp_psychologicalplacebo_NA_NA";1,28312885936421;0,522153066262954;NA;NA;NA;NA;NA;NA
"52";"Mancebo,2021";1;"erp";"cau";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"16";20,1;8;25;26;8,7;14;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"28.2";"4.5";31;"29.2";"4.9000000000000004";16;"8";"4";2021;"n";"oth";"22";"N America";"adul";38;"0.74";"0.79";"0.67";"clin";"adul";"Some concerns";"High risk";"Low risk";"Low risk";"Some concerns";"2";"Mancebo, M. C., Yip, A. G., Boisseau, C. L., Rasmussen, S. A., & Zlotnick, C. (2021). Behavioral Therapy Teams for Obsessive-Compulsive Disorder: Lessons Learned From a Pilot Randomized Trial in a Community Mental Health Center. Behav Ther, 52(5), 1296-1309.";"Mancebo_2021_msd_ybocs_post_16_cr_erp_cau_NA_NA";0,700326154253092;0,343483920094738;NA;NA;NA;NA;NA;NA
"53";"Mathur,2021";1;"third-wave";"psychological placebo";"NA";"NA";0;2;"msd";"itt";"ybocs";"cr";"post";"12";13,73;6,73;30;17,51;6,57;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26.24";"6.57";30;"26.46";"5.64";30;"1";"2";2021;"n";"ind";"12";"oth";"adul";28;"0.33";"0.7";"0.83";"clin";"adul";"Low risk";"Low risk";"Low risk";"Low risk";"Low risk";"0";"Mathur, S., Sharma, M. P., Balachander, S., Kandavel, T., & Reddy, Y. C. J. (2021). A randomized controlled trial of mindfulness-based cognitive therapy vs stress management training for obsessive-compulsive disorder. Journal of Affective Disorders, 282, 58-68.";"Mathur_2021_msd_ybocs_post_12_cr_third-wave_psychologicalplacebo_NA_NA";0,560998367905813;0,263360585186499;NA;NA;NA;NA;NA;NA
"54";"Matsumoto,2022";1;"cbt";"wl";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"12";14,71;5,65;14;20,87;7,23;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22.5";"4.1500000000000004";14;"24.31";"6.28";16;"1";"0";2022;"n";"gsh";"12";"oth";"adul";30;"0.56999999999999995";"NR";"NR";"com";"adul";"Low risk";"Some concerns";"Low risk";"Low risk";"Low risk";"1";"Matsumoto, K., Hamatani, S., Makino, T., Takahashi, J., Suzuki, F., Ida, T., . . . Omori, I. M. (2022). Guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: A multicenter randomized controlled trial in Japan. Internet interventions, 28, 100515.";"Matsumoto_2022_msd_ybocs_post_12_cr_cbt_wl_NA_NA";0,915873173289068;0,385611776072033;NA;NA;NA;NA;NA;NA
"55";"Matsumoto,2022";1;"cbt";"wl";"NA";"NA";0;2;"msd";"co";"oci";"sr";"post";"12";14,71;5,65;14;20,87;7,23;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"22.5";"4.1500000000000004";14;"24.31";"6.28";16;"1";"0";2022;"n";"gsh";"12";"oth";"adul";30;"0.56999999999999995";"NR";"NR";"com";"adul";"Low risk";"Some concerns";"Low risk";"Low risk";"Low risk";"1";"Matsumoto, K., Hamatani, S., Makino, T., Takahashi, J., Suzuki, F., Ida, T., . . . Omori, I. M. (2022). Guided internet-based cognitive behavioral therapy for obsessive-compulsive disorder: A multicenter randomized controlled trial in Japan. Internet interventions, 28, 100515.";"Matsumoto_2022_msd_oci_post_12_sr_cbt_wl_NA_NA";0,915873173289068;0,385611776072033;NA;NA;NA;NA;NA;NA
"56";"Norman,2021";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"12";12,96;7,96;42;21,3;8,16;45;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.1";"5.41";42;"27.4";"4.59";47;"0";"2";2021;"n";"ind";"12";"N America";"adul";24;"0.66";"0.48";"0.42";"com";"adul and adol";"Some concerns";"Some concerns";"Low risk";"Low risk";"Low risk";"2";"Norman, L. J., Mannella, K. A., Yang, H., Angstadt, M., Abelson, J. L., Himle, J. A., . . . Taylor, S. F. (2021). Treatment-Specific Associations Between Brain Activation and Symptom Reduction in OCD Following CBT: A Randomized fMRI Trial. Am J Psychiatry, 178(1), 39-47.";"Norman_2021_msd_ybocs_post_12_cr_erp_psychologicalplacebo_NA_NA";1,02505484540983;0,228426755511978;NA;NA;NA;NA;NA;NA
"57";"O'Connor,1999";1;"cbt";"no treatment";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"20";13,3;8,6;6;17,5;4;6;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"23.5";"4";6;"19.3";"4.5";6;"NR";"NR";1999;"n";"ind";"20";"N America";"adul";37;"0.42";"NR";"NR";"clin";"adul";"High risk";"High risk";"High risk";"Low risk";"Some concerns";"2";"O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study. The Canadian Journal of Psychiatry, 44(1), 64-71.";"O'Connor_1999_msd_ybocs_post_20_cr_cbt_notreatment_NA_NA";0,578066042966244;0,591332333932196;NA;NA;NA;NA;NA;NA
"58";"O'Connor,1999";1;"cbt";"no treatment";"NA";"NA";0;2;"msd";"co";"nimh-oc";"cr";"post";"20";3;3;6;7,2;0,8;6;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"8.8000000000000007";"1.3";6;"6.3";"0.8";6;"NR";"NR";1999;"n";"ind";"20";"N America";"adul";37;"0.42";"NR";"NR";"clin";"adul";"High risk";"High risk";"High risk";"Low risk";"Some concerns";"2";"O'Connor, K., Todorov, C., Robillard, S., Borgeat, F., & Brault, M. (1999). Cognitive-behaviour therapy and medication in the treatment of obsessive-compulsive disorder: a controlled study. The Canadian Journal of Psychiatry, 44(1), 64-71.";"O'Connor_1999_msd_nimh-oc_post_20_cr_cbt_notreatment_NA_NA";1,76589007239874;0,697010014195887;NA;NA;NA;NA;NA;NA
"59";"O'Connor,2006";1;"cbt";"pill placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"22";13,3;9,7;10;25,4;3,5;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"28.5";"4.5";10;"27.3";"4.3";10;"NR";"NR";2006;"n";"ind";"20";"N America";"adul";37;"0.7";"0";"0";"com";"adul";"Low risk";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"O'Connor, K. P., Aardema, F., Robillard, S., Guay, S., Pélissier, M. C., Todorov, C., . . . Doucet, P. (2006). Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr Scand, 113(5), 408-419.";"O'Connor_2006_msd_ybocs_post_22_cr_cbt_pillplacebo_NA_NA";1,5892879996522;0,518498323590996;NA;NA;NA;NA;NA;NA
"60";"O'Connor,2006";1;"cbt";"pill placebo";"NA";"NA";0;2;"msd";"co";"padua";"sr";"post";"22";42,6;24,1;10;90,6;45;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"86.8";"22.5";10;"96";"28.1";10;"NR";"NR";2006;"n";"ind";"20";"N America";"adul";37;"0.7";"0";"0";"com";"adul";"Low risk";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"O'Connor, K. P., Aardema, F., Robillard, S., Guay, S., Pélissier, M. C., Todorov, C., . . . Doucet, P. (2006). Cognitive behaviour therapy and medication in the treatment of obsessive-compulsive disorder. Acta Psychiatr Scand, 113(5), 408-419.";"O'Connor_2006_msd_padua_post_22_sr_cbt_pillplacebo_NA_NA";1,2736069666587;0,49417497145669;NA;NA;NA;NA;NA;NA
"61";"Piacentini,2011";1;"cbt";"psychological placebo";"NA";"NA";0;2;"msd";"co";"cy-bocs";"cr";"post";"14";13,3;8,4;40;17,2;8,8;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.7";"4.5999999999999996";49;"25.3";"4.5";22;"9";"5";2011;"n";"FB";"12";"N America";"child";12;"0.63";"0";"0";"com";"adol";"Some concerns";"High risk";"Some concerns";"Low risk";"Low risk";"2";"Piacentini, J., Bergman, R. L., Chang, S., Langley, A., Peris, T., Wood, J. J., & McCracken, J. (2011). Controlled comparison of family cognitive behavioral therapy and psychoeducation/relaxation training for child obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry, 50(11), 1149-1161.";"Piacentini_2011_msd_cy-bocs_post_14_cr_cbt_psychologicalplacebo_NA_NA";0,451566019215729;0,292681159615566;NA;NA;NA;NA;NA;NA
"62";"POST,2004";1;"cbt";"pill placebo";"cbt";"pill placebo";1;3;"msd";"itt";"cy-bocs";"cr";"post";"12";14;9,5;28;21,5;5,4;28;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26";"4.5999999999999996";28;"25.2";"3.3";28;"3";"7";2004;"n";"ind";"14";"N America";"child";12;"0.5";"NR";"NR";"com";"adol and child";"Some concerns";"Some concerns";"Some concerns";"Low risk";"Some concerns";"2";"Team, P. O. T. S. P. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. Jama, 292(16), 1969-1976.";"POST_2004_msd_cy-bocs_post_12_cr_cbt_pillplacebo_cbt_pillplacebo";0,957091177851022;0,282560552134661;NA;NA;NA;NA;NA;NA
"63";"Rezvan,2013";1;"other psy";"no treatment";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"8";24,08;3,5;12;28,83;3,21;12;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"29.91";"3.2";12;"29.16";"2.69";12;"0";"0";2012;"n";"oth";"8";"oth";"child";10;"1";"0";"0";"clin";"child";"Some concerns";"Some concerns";"Low risk";"Some concerns";"Some concerns";"2";"Rezvan, S., Bahrami, F., Abedi, M., Macleod, C., Doost, H. T. N., & Ghasemi, V. (2013). A preliminary study on the effects of attachment-based intervention on pediatric obsessive-compulsive disorder. International journal of preventive medicine, 4(1), 78.";"Rezvan_2013_msd_cy-bocs_post_8_cr_otherpsy_notreatment_NA_NA";1,36570182595744;0,456452463654361;NA;NA;NA;NA;NA;NA
"64";"Rupp,2019";1;"other psy";"wl";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"2";20,4;6,71;20;23,6;2,39;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.5";"3.82";20;"23.85";"2.74";20;"2";"1";2019;"n";"ind";"4";"eu";"adul";31;"0.57999999999999996";"0.36";"0.52";"com";"adul";"Low risk";"High risk";"Some concerns";"Low risk";"Low risk";"2";"Rupp, C., Jürgens, C., Doebler, P., Andor, F., & Buhlmann, U. (2019). A randomized waitlist-controlled trial comparing detached mindfulness and cognitive restructuring in obsessive-compulsive disorder. PLoS One, 14(3), e0213895.";"Rupp_2019_msd_ybocs_post_2_cr_otherpsy_wl_NA_NA";0,622717077319245;0,324107554694402;NA;NA;NA;NA;NA;NA
"65";"Russell,2013";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"27";17,8;8,4;20;20,8;7,8;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.8";"3.7";23;"25.1";"5.0999999999999996";23;"3";"3";2013;"y";"ind";"17";"uk";"adul";27;"0.24";"NR";"NR";"oth";"adul and adol";"Low risk";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708.";"Russell_2013_msd_ybocs_post_27_cr_erp_psychologicalplacebo_NA_NA";0,362763295063727;0,318923703677107;NA;NA;NA;NA;NA;NA
"66";"Russell,2013";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"co";"oci-r";"sr";"post";"27";26,8;15,3;20;30,9;13,4;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"31.5";"12.7";23;"30.3";"11.9";23;"3";"3";2013;"y";"ind";"17";"uk";"adul";27;"0.24";"NR";"NR";"oth";"adul and adol";"Low risk";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708.";"Russell_2013_msd_oci-r_post_27_sr_erp_psychologicalplacebo_NA_NA";0,279426189467755;0,317830073337861;NA;NA;NA;NA;NA;NA
"67";"Russell,2013";1;"erp";"psychological placebo";"NA";"NA";0;2;"msd";"co";"d-ybocs";"cr";"post";"27";15,5;7,1;20;17,1;7,5;20;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"20.7";"3.8";23;"20.3";"4.7";23;"3";"3";2013;"y";"ind";"17";"uk";"adul";27;"0.24";"NR";"NR";"oth";"adul and adol";"Low risk";"High risk";"Some concerns";"Low risk";"Some concerns";"2";"Russell, A. J., Jassi, A., Fullana, M. A., Mack, H., Johnston, K., Heyman, I., . . . Mataix-Cols, D. (2013). Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety, 30(8), 697-708.";"Russell_2013_msd_d-ybocs_post_27_cr_erp_psychologicalplacebo_NA_NA";0,214742971778394;0,317175089662388;NA;NA;NA;NA;NA;NA
"68";"Russman Block,2023";1;"erp";"psychological placebo";"a";"psychological placebo";0;2;"msd";"co";"ybocs";"cr";"post";"12";13,46;9,62;27;21,73;8,49;27;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"26.19";"5.34";27;"27.61";"5.04";27;"NR";"NR";2023;"n";"ind";"12";"N America";"adol";16;"0.67";"0.67";"0.56000000000000005";"com";"adol";"High risk";"High risk";"High risk";"Low risk";"Some concerns";"2";"Russman Block, S., Norman, L. J., Zhang, X., Mannella, K. A., Yang, H., Angstadt, M., . . . Fitzgerald, K. D. (2023). Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial. Am J Psychiatry, 180(1), 89-99. doi:10.1176/appi.ajp.21111173";"RussmanBlock_2023_msd_ybocs_post_12_cr_erp_psychologicalplacebo_a_psychologicalplacebo";0,898324190839432;0,28595026383483;NA;NA;NA;NA;NA;NA
"69";"Russman Block,2023";1;"erp";"psychological placebo";"b";"psychological placebo";0;2;"msd";"co";"ybocs";"cr";"post";"12";11,62;6,24;31;23,08;7,29;31;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"23.76";"5.15";31;"26.9";"4.68";31;"NR";"NR";2023;"n";"ind";"12";"N America";"adul";32;"0.52";"0.45";"0.42";"com";"adul";"High risk";"High risk";"High risk";"Low risk";"Some concerns";"2";"Russman Block, S., Norman, L. J., Zhang, X., Mannella, K. A., Yang, H., Angstadt, M., . . . Fitzgerald, K. D. (2023). Resting-State Connectivity and Response to Psychotherapy Treatment in Adolescents and Adults With OCD: A Randomized Clinical Trial. Am J Psychiatry, 180(1), 89-99. doi:10.1176/appi.ajp.21111173";"RussmanBlock_2023_msd_ybocs_post_12_cr_erp_psychologicalplacebo_b_psychologicalplacebo";1,66773503839532;0,295838088306778;NA;NA;NA;NA;NA;NA
"70";"Storch,2011";1;"cbt";"wl";"cbt";"wl";1;3;"msd";"itt";"cy-bocs";"cr";"post";"12";11,13;10,53;16;18,53;8,11;15;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.38";"3.61";16;"21.27";"2.74";15;"2";"0";2011;"n";"FB";"14";"N America";"child";11;"0.39";"0.56000000000000005";"0.53";"com";"adol and child";"High risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Storch, E. A., Caporino, N. E., Morgan, J. R., Lewin, A. B., Rojas, A., Brauer, L., . . . Murphy, T. K. (2011). Preliminary investigation of web-camera delivered cognitive-behavioral therapy for youth with obsessive-compulsive disorder. Psychiatry Res, 189(3), 407-412.";"Storch_2011_msd_cy-bocs_post_12_cr_cbt_wl_cbt_wl";0,763488890325518;0,372932893090299;NA;NA;NA;NA;NA;NA
"71";"Twohig,2010";1;"third-wave";"psychological placebo";"NA";"NA";0;2;"msd";"itt";"ybocs";"cr";"post";"9";12,76;8,35;36;18,67;5,68;33;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.22";"4.8";41;"25.4";"5.26";38;"0";"0";2010;"n";"ind";"8";"N America";"adul";37;"0.66";"0.34";"0.44";"com";"adul";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Twohig, M. P., Hayes, S. C., Plumb, J. C., Pruitt, L. D., Collins, A. B., Hazlett-Stevens, H., & Woidneck, M. R. (2010). A randomized clinical trial of acceptance and commitment therapy versus progressive relaxation training for obsessive-compulsive disorder. J Consult Clin Psychol, 78(5), 705-716.";"Twohig_2010_msd_ybocs_post_9_cr_third-wave_psychologicalplacebo_NA_NA";0,811680095239471;0,250926319422457;NA;NA;NA;NA;NA;NA
"72";"van-Balkom,1998";1;"ct";"wl";"ct";"wl";1;3;"msd";"co";"ybocs";"cr";"post";"8";21,5;10,4;25;26,4;6,8;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25.3";"6.6";25;"26.8";"6.4";18;"0";"2";1998;"NR";"ind";"6";"eu";"adul";35;"0.63";"0.16";"0.06";"com";"adul";"Some concerns";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499.";"van-Balkom_1998_msd_ybocs_post_8_cr_ct_wl_ct_wl";0,523213918715041;0,325532686811348;NA;NA;NA;NA;NA;NA
"73";"van-Balkom,1998";1;"ct";"wl";"ct";"wl";1;3;"msd";"co";"padua";"sr";"post";"8";61,2;25,5;25;68,6;34,6;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"71.900000000000006";"21";25;"67.099999999999994";"31";18;"0";"2";1998;"NR";"ind";"6";"eu";"adul";35;"0.63";"0.16";"0.06";"com";"adul";"Some concerns";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499.";"van-Balkom_1998_msd_padua_post_8_sr_ct_wl_ct_wl";0,247367670138564;0,321365797684674;NA;NA;NA;NA;NA;NA
"74";"van-Balkom,1998";1;"erp";"wl";"erp";"wl";1;3;"msd";"co";"ybocs";"cr";"post";"8";18,6;8,5;20;26,4;6,8;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"25";"7.9";22;"26.8";"6.4";18;"2";"2";1998;"NR";"ind";"6";"eu";"adul";35;"0.54";"0.16";"0.06";"com";"adul";"Some concerns";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499.";"van-Balkom_1998_msd_ybocs_post_8_cr_erp_wl_erp_wl";0,978300513863116;0,355533041102382;NA;NA;NA;NA;NA;NA
"75";"van-Balkom,1998";1;"erp";"wl";"erp";"wl";1;3;"msd";"co";"padua";"sr";"post";"8";58;23,3;20;68,6;34,6;16;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"65.2";"18.7";22;"67.099999999999994";"31";18;"2";"2";1998;"NR";"ind";"6";"eu";"adul";35;"0.54";"0.16";"0.06";"com";"adul";"Some concerns";"Some concerns";"Low risk";"Low risk";"Some concerns";"2";"van Balkom, A. J., de Haan, E., van Oppen, P., Spinhoven, P., Hoogduin, K. A., & van Dyck, R. (1998). Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. The Journal of nervous and mental disease, 186(8), 492-499.";"van-Balkom_1998_msd_padua_post_8_sr_erp_wl_erp_wl";0,359422151403439;0,338196257601311;NA;NA;NA;NA;NA;NA
"76";"Vogel,2014";1;"erp";"wl";"erp(vct)";"wl";1;3;"msd";"itt";"ybocs";"cr";"post";"12";11,5;4,8;10;23,4;4,8;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.2";"4.3";10;"23.4";"2.8";10;"0";"2";2014;"n";"oth";"12";"eu";"adul";35;"0.55000000000000004";"NR";"NR";"clin";"adul";"Some concerns";"some concerns";"High risk";"Low risk";"Some concerns";"2";"Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168.";"Vogel_2014_msd_ybocs_post_12_cr_erp_wl_erp(vct)_wl";2,37441314553991;0,594690410236938;NA;NA;NA;NA;NA;NA
"77";"Vogel,2014";1;"erp";"wl";"erp(vct)";"wl";1;3;"msd";"itt";"voci";"sr";"post";"12";28,1;21,5;10;65,5;22,3;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"60.8";"30.2";10;"63.7";"23.1";10;"0";"2";2014;"n";"oth";"12";"eu";"adul";35;"0.55000000000000004";"NR";"NR";"clin";"adul";"Some concerns";"some concerns";"High risk";"Low risk";"Some concerns";"2";"Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168.";"Vogel_2014_msd_voci_post_12_sr_erp_wl_erp(vct)_wl";1,63533082177066;0,522385880703309;NA;NA;NA;NA;NA;NA
"78";"Vogel,2014";1;"erp";"wl";"erp(ush)";"wl";1;3;"msd";"itt";"ybocs";"cr";"post";"12";22,7;5,6;10;23,4;4,8;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.1";"2.7";10;"23.4";"2.8";10;"1";"2";2014;"n";"ush";"12";"eu";"adul";35;"0.6";"NR";"NR";"clin";"adul";"Some concerns";"Low risk";"Some concerns";"Low risk";"some concerns";"2";"Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168.";"Vogel_2014_msd_ybocs_post_12_cr_erp_wl_erp(ush)_wl";0,128547653060334;0,447716838690549;NA;NA;NA;NA;NA;NA
"79";"Vogel,2014";1;"erp";"wl";"erp(ush)";"wl";1;3;"msd";"itt";"voci";"sr";"post";"12";57,4;40,1;10;65,5;22,3;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"64.900000000000006";"32";10;"63.7";"23.1";10;"1";"2";2014;"n";"ush";"12";"eu";"adul";35;"0.6";"NR";"NR";"clin";"adul";"Some concerns";"Low risk";"Some concerns";"Low risk";"some concerns";"2";"Vogel, P. A., Solem, S., Hagen, K., Moen, E. M., Launes, G., Håland, Å. T., . . . Himle, J. A. (2014). A pilot randomized controlled trial of videoconference-assisted treatment for obsessive-compulsive disorder. Behaviour Research and Therapy, 63, 162-168.";"Vogel_2014_msd_voci_post_12_sr_erp_wl_erp(ush)_wl";0,239107712945912;0,448952347394822;NA;NA;NA;NA;NA;NA
"80";"Whittal,2010";1;"ct";"psychological placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"12";6,43;4,77;37;9,1;6,48;30;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"18.03";"6.29";37;"17.73";"7.73";30;"0";"0";2009;"n";"ind";"12";"N America";"adul";32;"0.46";"0.52";"0.52";"com";"adul";"Some concerns";"NR";"NR";"Low risk";"NR";"NR";"Whittal, M. L., Woody, S. R., McLean, P. D., Rachman, S. J., & Robichaud, M. (2010). Treatment of obsessions: a randomized controlled trial. Behav Res Ther, 48(4), 295-303.";"Whittal_2010_msd_ybocs_post_12_cr_ct_psychologicalplacebo_NA_NA";0,471445153890758;0,249114679811849;NA;NA;NA;NA;NA;NA
"81";"Wilhelm,2009";1;"ct";"wl";"NA";"NA";0;2;"change";"itt";"ybocs";"cr";"post";"12";NA;NA;NA;NA;NA;NA;-9,92;0,46;6,7;3,8;12;12;NA;NA;NA;NA;NA;NA;NA;NA;"26.5";"4.7";15;"24.6";"4.7";14;"3";"2";2009;"n";"ind";"12";"N America";"adul";33;"0.52";"0.48";"0.48";"com";"adul";"High risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Wilhelm, S., Steketee, G., Fama, J. M., Buhlmann, U., Teachman, B. A., & Golan, E. (2009). Modular cognitive therapy for obsessive-compulsive disorder: A wait-list controlled trial. Journal of Cognitive Psychotherapy, 23(4), 294-305.";"Wilhelm_2009_change_ybocs_post_12_cr_ct_wl_NA_NA";1,84007366854321;0,492274435548278;NA;NA;NA;NA;NA;NA
"82";"Williams,2010";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"12";12,09;7,46;11;19,6;6,4;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"23.09";"4.04";11;"21.05";"5.82";10;"1";"1";2010;"n";"ind";"10";"uk";"adol";14;"0.38";"0.33";"0.33";"clin";"child and adol";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Williams, T. I., Salkovskis, P. M., Forrester, L., Turner, S., White, H., & Allsopp, M. A. (2010). A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents. Eur Child Adolesc Psychiatry, 19(5), 449-456.";"Williams_2010_msd_cy-bocs_post_12_cr_cbt_wl_NA_NA";1,0331906936259;0,467426465165024;NA;NA;NA;NA;NA;NA
"83";"Williams,2010";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"oci";"sr";"post";"12";45;27,5;11;60,3;30,4;10;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"59.3";"27.5";11;"73.55";"26.1";10;"1";"1";2010;"n";"ind";"10";"uk";"adol";14;"0.38";"0.33";"0.33";"clin";"child and adol";"Low risk";"Low risk";"Some concerns";"Low risk";"Some concerns";"2";"Williams, T. I., Salkovskis, P. M., Forrester, L., Turner, S., White, H., & Allsopp, M. A. (2010). A randomised controlled trial of cognitive behavioural treatment for obsessive compulsive disorder in children and adolescents. Eur Child Adolesc Psychiatry, 19(5), 449-456.";"Williams_2010_msd_oci_post_12_sr_cbt_wl_NA_NA";0,508060037278917;0,444497184364503;NA;NA;NA;NA;NA;NA
"84";"Wolters,2016";1;"cbt";"wl";"NA";"NA";0;2;"msd";"itt";"cy-bocs";"cr";"post";"8";19,84;4,92;19;24,27;6,12;22;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"24.21";"3.61";20;"24.59";"3.98";24;"1";"2";2016;"y";"ind";"8";"eu";"child";12,5;"0.61";"0";"0";"clin";"child and adol";"Some concerns";"Low risk";"some concerns";"Low risk";"Some concerns";"2";"Wolters, L. H., de Haan, E., Hogendoorn, S. M., Boer, F., & Prins, P. J. M. (2016). Severe pediatric obsessive compulsive disorder and co-morbid autistic symptoms: Effectiveness of cognitive behavioral therapy. Journal of Obsessive-Compulsive and Related Disorders, 10, 69-77.";"Wolters_2016_msd_cy-bocs_post_8_cr_cbt_wl_NA_NA";0,776008621491588;0,325150186567715;NA;NA;NA;NA;NA;NA
"85";"Wootton,2013";1;"cbt";"wl";"cbt(bibli)";"wl";1;3;"msd";"itt";"ybocs";"cr";"post";"8";13,27;5,23;20;20,49;5,07;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"21.8";"5.0999999999999996";20;"21.06";"5.1100000000000003";17;"5";"5";2013;"n";"gsh";"4.33";"au";"adul";37;"0.68";"0.5";"0.77";"com";"adul";"Low risk";"Low risk";"Some concerns";"High risk";"High risk";"2";"Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384.";"Wootton_2013_msd_ybocs_post_8_cr_cbt_wl_cbt(bibli)_wl";1,36969646806253;0,367840487509281;NA;NA;NA;NA;NA;NA
"86";"Wootton,2013";1;"cbt";"wl";"cbt(bibli)";"wl";1;3;"msd";"itt";"docs";"sr";"post";"8";8,05;4,25;20;10,66;4,04;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"12.5";"3.49";20;"11.94";"3.5";17;"5";"3";2013;"n";"gsh";"4";"au";"adul";37;"0.68";"0.5";"0.77";"com";"adul";"Low risk";"Low risk";"Some concerns";"High risk";"High risk";"2";"Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384.";"Wootton_2013_msd_docs_post_8_sr_cbt_wl_cbt(bibli)_wl";0,614554561829371;0,337868207450282;NA;NA;NA;NA;NA;NA
"87";"Wootton,2013";1;"cbt";"wl";"cbt(internet)";"wl";1;3;"msd";"itt";"ybocs";"cr";"post";"8";12,38;5,27;15;20,49;5,07;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"23.53";"5.07";15;"21.06";"5.1100000000000003";17;"6";"5";2013;"n";"gsh";"4";"au";"adul";39;"0.78";"0.6";"0.77";"com";"adul";"Low risk";"Low risk";"Some concerns";"High risk";"High risk";"2";"Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384.";"Wootton_2013_msd_ybocs_post_8_cr_cbt_wl_cbt(internet)_wl";1,53080772654583;0,404998478259772;NA;NA;NA;NA;NA;NA
"88";"Wootton,2013";1;"cbt";"wl";"cbt(internet)";"wl";1;3;"msd";"itt";"docs";"sr";"post";"8";7,93;4,38;15;10,66;4,04;17;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"12.07";"3.49";15;"11.94";"3.5";17;"7";"3";2013;"n";"gsh";"4";"au";"adul";39;"0.78";"0.6";"0.77";"com";"adul";"Low risk";"Low risk";"Some concerns";"High risk";"High risk";"2";"Wootton, B. M., Dear, B. F., Johnston, L., Terides, M. D., & Titov, N. (2013). Remote treatment of obsessive-compulsive disorder: A randomized controlled trial. Journal of Obsessive-Compulsive and Related Disorders, 2(4), 375-384.";"Wootton_2013_msd_docs_post_8_sr_cbt_wl_cbt(internet)_wl";0,633298071576663;0,363435260411514;NA;NA;NA;NA;NA;NA
"89";"Zejuan-Fu,2016";1;"cbt";"cau";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"NR";20,68;2,83;50;25,98;3,26;50;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"29.16";"4.79";50;"29.22";"5.03";50;"0";"0";2016;"n";"oth";"NR";"oth";"adul";33;"0.55000000000000004";"0.56000000000000005";"0.54";"clin";"adul";"Some concerns";"Some concerns";"Low risk";"Some concerns";"Some concerns";"2";"符泽娟, & 谢海玲. (2016). 认知行为干预疗法对改善强迫症患者心理状态及生活质量的效果评价. 实用临床医药杂志, 20(8), 17-20.";"Zejuan-Fu_2016_msd_ybocs_post_NR_cr_cbt_cau_NA_NA";1,72291423332595;0,234675462372427;NA;NA;NA;NA;NA;NA
"90";"Zhang,2021";1;"third-wave";"psychological placebo";"NA";"NA";0;2;"msd";"co";"ybocs";"cr";"post";"10";13,54;6,1;28;14,97;4;29;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;"21.18";"3.3";28;"19.79";"3.7";29;"14";"11";2021;"n";"grp";"11";"oth";"adul";29;"0.32";"0";"0";"clin";"adul";"High risk";"High risk";"Some concerns";"Low risk";"Low risk";"2";"Zhang, T., Lu, L., Didonna, F., Wang, Z., Zhang, H., & Fan, Q. (2021). Mindfulness-Based Cognitive Therapy for Unmedicated Obsessive-Compulsive Disorder: A Randomized Controlled Trial With 6-Month Follow-Up. Frontiers in Psychiatry, 12.";"Zhang_2021_msd_ybocs_post_10_cr_third-wave_psychologicalplacebo_NA_NA";0,274437550684144;0,266225825230024;NA;NA;NA;NA;NA;NA
